Phase III randomized trial comparing systemic versus intra-arterial oxaliplatin, combined with LV5FU2 +/- irinotecan and a targeted therapy, in the first-line treatment of metastatic colorectal cancer restricted to the liver (OSCAR): PRODIGE 49
Titel:
Phase III randomized trial comparing systemic versus intra-arterial oxaliplatin, combined with LV5FU2 +/- irinotecan and a targeted therapy, in the first-line treatment of metastatic colorectal cancer restricted to the liver (OSCAR): PRODIGE 49
Auteur:
Pernot, Simon Pellerin, Olivier Mineur, Laurent Monterymard, Carole Smith, Denis Lapuyade, Bruno Gallois, Claire Khemissa Akouz, Faiza De Baere, Thierry Tougeron, David Thirot-Bidault, Anne Audemar, Franck Simon, Mireille Lecaille, Cedric Louafi, Sami Lepage, Come Ducreux, Michel Taieb, Julien